current page

Top Management Message

Evolving as a Global Corporation with Unique Excellence

I want to express my deepest gratitude to our shareholders for your understanding and support for the Terumo Group activities.

In the last fiscal year, Terumo Group achieved its highest-ever sales and profit results for a great first year of our Mid- to Long-term Growth Strategy. In addition, the integration of the three businesses we acquired in FY2016 went even more smoothly than we anticipated. Having now practically integrated Vascutek and the newly acquired Bolton Medical, we announced in April 2018 our new brand for the Vascular Graft business of the Cardiac and Vascular Company: Terumo Aortic. We will increase our global presence by strengthening the Terumo brand in each of the fields where we do business.

Overseas sales account for 68% of total Terumo sales, and we expect that percentage to increase going forward. We find demand for Terumo's products is increasing in the United States and emerging nations, but competition is also growing more severe as the movement for downward pressure on healthcare expenditures continues globally. Terumo plans to pursue not only functionality and product quality, but also a more comprehensive solution called "Total Quality," which also covers areas including supply chain and services such as maintenance and training. Terumo will also strengthen the global operations that underpin its sustainable growth. Specifically, we have begun a group-wide project called “Production Renaissance Project” to enhance our production infrastructure, which is our highest priority as management. We will review all our thirty factories around the world from the perspective of overall optimization, raising productivity and strengthening production capacity in a timely manner.

We are also making proactive investments in our internal strategic development function toward raising the competitiveness of our products in the global market. We have also improved our Shonan Center and Ashitaka Plant development environments to cultivate a free, creative culture. In addition, we established a development base in Silicon Valley, California, to enable collaboration on new technologies between our U.S. and Japanese associates. Through global CTO*, We are promoting diverse collaborations such as sharing of core technologies toward creating development synergies across the Terumo Group.

We ask for your continued understanding and support in this endeavor.

June 2018

* Chief Technology Officer

 

Shinjiro Sato
President and CEO


Return to page top